# A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome

> **NCT01763580** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Korea, Inc.** · enrollment: 144 (actual)

## Conditions studied

- MCNS
- Minimal Change Nephrotic Syndrome (MCNS)

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT01763580
- **Lead sponsor:** Astellas Pharma Korea, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-16
- **Primary completion:** 2017-05-02
- **Final completion:** 2017-08-21
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01763580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01763580, "A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01763580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*